Cargando…
Adjuvant Iodine(131) Lipiodol after Resection of Hepatocellular Carcinoma
Background. Survival after liver resection for HCC is compromised by a high rate of intrahepatic recurrence. Adjuvant treatment with a single, postoperative dose of intra-arterial I(131) lipiodol has shown promise, as a means of prolonging disease-free survival (DFS). Methodology. DFS and overall su...
Autores principales: | Furtado, Ruelan V., Ha, Leo, Clarke, Stephen, Sandroussi, Charbel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680111/ https://www.ncbi.nlm.nih.gov/pubmed/26713092 http://dx.doi.org/10.1155/2015/746917 |
Ejemplares similares
-
Nodular hepatocellular carcinoma--treatment with intraarterial injection of I-131 Lipiodol.
por: Yoo, H. S., et al.
Publicado: (1990) -
Transarterial Radioembolization (TARE) with
(131)
Iodine-Lipiodol for Unresectable Primary Hepatocellular Carcinoma: Experience from a Tertiary Care Center in India
por: Patel, Aakash, et al.
Publicado: (2021) -
Preparation and Characterization of Hyaluronic Acid-Polycaprolactone Copolymer Micelles for the Drug Delivery of Radioactive Iodine-131 Labeled Lipiodol
por: Chen, Shih-Cheng, et al.
Publicado: (2017) -
Transarterial radioembolization with Iodine-131-Lipiodol for hepatic metastases from gastrointestinal malignancies – Experience in tertiary care oncology center in India
por: Bhargavi, Vidya, et al.
Publicado: (2019) -
Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Lin, Ming-Tzer, et al.
Publicado: (2010)